|  | |
|  | |
| Clinical data | |
|---|---|
| Routes of administration | Oral | 
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | 
 | 
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H16N2 | 
| Molar mass | 188.274 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
| (verify) | |
4-Methyl-α-methyltryptamine (4-Me-αMT), also known as 4,α-dimethyltryptamine (4,α-DMT), and MP-809, is a drug belonging to the tryptamine class that was investigated as an antidepressant in the early 1960s but was never marketed.[1][2]
See also
- 4-Methyl-αET
- α-Ethyltryptamine (αET)
- α-Methyltryptamine (αMT)
References
- ↑ Azima H, Arthurs D, Silver A, Azima FJ (December 1962). "The effect of MP-809 in depressive states: a multi-blind study". The American Journal of Psychiatry. 119 (6): 573–4. doi:10.1176/ajp.119.6.573. PMID 13965759.
- ↑ Brodey JF, Steiner WG, Himwich HE (April 1963). "An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809)". The Journal of Pharmacology and Experimental Therapeutics. 140: 8–18. PMID 14015664.
| 
 | |||||||||||||||||||||
| 
 | |||||||||||||||||||||
| 
 | |||||||||||||||||||||
| 
 | |||||||||||||||||||||
| 
 | |||||||||||||||||||||
| 5-HT1 | 
 | ||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-HT2 | 
 | ||||||||||||||||||||||||||||||||||||||
| 5-HT3–7 | 
 | ||||||||||||||||||||||||||||||||||||||
| 
 | |||||||||||||||||||||||||||||||||||||||
| DRAsTooltip Dopamine releasing agents | 
 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRAsTooltip Norepinephrine releasing agents | 
 | ||||||||||||||
| SRAsTooltip Serotonin releasing agents | 
 | ||||||||||||||
| Others | 
 
 | ||||||||||||||
| See also: Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins | |||||||||||||||
| 
 | 
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
